Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like
growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure
Easy to read patient leaflet for mecasermin. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Jun 16, 2014 ... INCRELEX® (mecasermin [rDNA origin] injection) contains human insulin-like
growth factor-1 (rhIGF-1) produced by recombinant DNA ...
Pictures of Increlex (Mecasermin [rDNA origin] Injection), drug imprint information
, side effects for the patient.
Nov 5, 2014 ... Mecasermin is a man-made form of insulin-like growth factor-1 (IGF-1), a
substance that is normally produced in the body. IGF-1 is important for ...
INCRELEX® (mecasermin [rDNA origin] injection) number of cases indicative of
anaphylaxis requiring hospitalization have been reported. Parents and patients ...
Aetna considers mecasermin (Increlex) and mecasermin rinfabate (Iplex)*
medically necessary for the treatment of growth failure in children with severe
INCRELEX (mecasermin) is recombinant human insulin-like growth factor-1 ...
Mecasermin was granted orphan status in the EU for “Treatment of growth ...
Apr 1, 2015 ... Mecasermin injection is a man-made version of insulin-like growth factor-1 (IGF-1
) hormone. IGF-1 is produced in the liver and plays an ...
Adv Ther. 2009 Jan;26(1):40-54. doi: 10.1007/s12325-008-0136-5. Epub 2009
Jan 28. Mecasermin (recombinant human insulin-like growth factor I).